James G. Wolf - Feb 10, 2023 Form 4 Insider Report for ENZO BIOCHEM INC (ENZ)

Role: 10% owner until 2/13/2023
Signature: James G. Wolf
Stock symbol: ENZ
Transactions as of: Feb 10, 2023
Transactions value $: $20,408
Form type: 4
Date filed: 2/13/2023, 08:41 PM
Previous filing: Jan 30, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ENZ	Common Stock, $0.01 par value	Purchase	$6.45K	+5K	+0.12%	$1.29	4.1M	Feb 10, 2023	Direct
transaction	ENZ	Common Stock, $0.01 par value	Purchase	$6.43K	+5K	+0.12%	$1.29	4.1M	Feb 13, 2023	Direct
transaction	ENZ	Common Stock, $0.01 par value	Purchase	$6.45K	+5K	+4.55%	$1.29	115K	Feb 13, 2023	See Footnote	F1
holding	ENZ	Common Stock, $0.01 par value						309K	Feb 10, 2023	See Footnote	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership
transaction	ENZ	Long Call Option (right to buy)	Sale	-$62	-324	-40.15%	$0.19^*	483	Feb 13, 2023	Common Stock, $0.01 par value	32.4K	$5.00	Direct
transaction	ENZ	Short Put Option (obligation to buy)	Sale	$327	+324		$1.01	324	Feb 13, 2023	Common Stock, $0.01 par value	32.4K	$2.50	Direct
transaction	ENZ	Short Put Option (obligation to buy)	Sale	-$23	-750	-100%	$0.03^*	0	Feb 13, 2023	Common Stock, $0.01 par value	75K	$7.50	Direct
transaction	ENZ	Short Put Option (obligation to buy)	Sale	$840	+750	+53.08%	$1.12	2.16K	Feb 13, 2023	Common Stock, $0.01 par value	75K	$2.50	Direct
holding	ENZ	Long Call Option (right to buy)						1K	Feb 10, 2023	Common Stock, $0.01 par value	100K	$2.50	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

James G. Wolf is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	The transaction was completed in the name and for the benefit of the Reporting Person's sibling. The Reporting Person maintains a power of attorney granted by the Reporting Person's sibling with respect to these shares, including voting and dispositive power over the shares. The Reporting Person has no pecuniary interest in the shares and disclaims beneficial ownership of the securities held by his sibling. This report will not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
F2	The 308,500 shares owned indirectly by the Reporting Person include 116,000 shares held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person, 22,000 shares held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person's spouse and 170,500 shares owned directly by adult children of the Reporting Person.

Content

The transaction was completed in the name and for the benefit of the Reporting Person's sibling. The Reporting Person maintains a power of attorney granted by the Reporting Person's sibling with respect to these shares, including voting and dispositive power over the shares. The Reporting Person has no pecuniary interest in the shares and disclaims beneficial ownership of the securities held by his sibling. This report will not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

The 308,500 shares owned indirectly by the Reporting Person include 116,000 shares held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person, 22,000 shares held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person's spouse and 170,500 shares owned directly by adult children of the Reporting Person.